Anti-Tac

muromonab-CD3 · Ortho Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Tac, covering 2012-08-09 to 2012-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Tac for Treatment of Leukemia [Phase 1, Phase 2]